Viewing Study NCT04018833


Ignite Creation Date: 2025-12-25 @ 2:47 AM
Ignite Modification Date: 2025-12-31 @ 10:36 PM
Study NCT ID: NCT04018833
Status: COMPLETED
Last Update Posted: 2019-07-23
First Post: 2019-07-10
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Intravitreal Ranibizumab or Aflibercept After Bevacizumab in Diabetic Macular Edema
Sponsor: Bernardete Pessoa MD
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module References Module